Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load

Subjective cognitive decline (SCD) is considered an early risk stage for dementia due to Alzheimer's disease (AD) and the development of pathological brain changes, such as the aggregation of amyloid-beta (amyloid-β) plaques. This study evaluates the association between specific features of SCD...

Full description

Bibliographic Details
Main Authors: Claudia Schwarz, Catharina Lange, Gloria S. Benson, Nora Horn, Katharina Wurdack, Mathias Lukas, Ralph Buchert, Miranka Wirth, Agnes Flöel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.675583/full
_version_ 1818600670864867328
author Claudia Schwarz
Claudia Schwarz
Catharina Lange
Gloria S. Benson
Gloria S. Benson
Nora Horn
Nora Horn
Katharina Wurdack
Katharina Wurdack
Mathias Lukas
Mathias Lukas
Ralph Buchert
Ralph Buchert
Miranka Wirth
Agnes Flöel
Agnes Flöel
author_facet Claudia Schwarz
Claudia Schwarz
Catharina Lange
Gloria S. Benson
Gloria S. Benson
Nora Horn
Nora Horn
Katharina Wurdack
Katharina Wurdack
Mathias Lukas
Mathias Lukas
Ralph Buchert
Ralph Buchert
Miranka Wirth
Agnes Flöel
Agnes Flöel
author_sort Claudia Schwarz
collection DOAJ
description Subjective cognitive decline (SCD) is considered an early risk stage for dementia due to Alzheimer's disease (AD) and the development of pathological brain changes, such as the aggregation of amyloid-beta (amyloid-β) plaques. This study evaluates the association between specific features of SCD and cerebral amyloid-β load measured by positron emission tomography (PET) with 18F-florbetaben in 40 cognitively normal older individuals. Global amyloid-β, as well as regional amyloid-β load for the frontal, temporal, parietal, and cingulate cortex, was quantified. Specific features of SCD, such as subjective cognitive complaints and worry, were assessed using the 39-item Everyday Cognition Scales and the 16-item Penn State Worry Questionnaire. Spearman's rank partial correlation analyses, adjusted for age and apolipoprotein E ε4 status, were conducted to test the associations between specific features of SCD and cerebral amyloid-β load. The severity of subjective cognitive complaints in everyday memory and organization was positively correlated with amyloid-β load in the frontal cortex. In addition, the severity of subjective cognitive complaints in everyday planning was positively correlated with amyloid-β load in the parietal cortex. Higher levels of worry were associated with higher amyloid-β load in the frontal cortex. After correction of the PET data for partial volume effects, these associations were reduced to trend level. In conclusion, the severity of subjective cognitive complaints and the level of trait worry were positively associated with cortical amyloid-β burden, particularly in the frontal and parietal cortex. Further studies are required to elucidate the direction of these associations in order to develop strategies to prevent amyloid deposition and cognitive decline.
first_indexed 2024-12-16T12:39:11Z
format Article
id doaj.art-7fed440c118e434cbdef2e21b7ed2e4e
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-16T12:39:11Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-7fed440c118e434cbdef2e21b7ed2e4e2022-12-21T22:31:28ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-08-011310.3389/fnagi.2021.675583675583Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β LoadClaudia Schwarz0Claudia Schwarz1Catharina Lange2Gloria S. Benson3Gloria S. Benson4Nora Horn5Nora Horn6Katharina Wurdack7Katharina Wurdack8Mathias Lukas9Mathias Lukas10Ralph Buchert11Ralph Buchert12Miranka Wirth13Agnes Flöel14Agnes Flöel15Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanySiemens Healthcare GmbH, Berlin, GermanyDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment for Diagnostic and Interventional Radiology and Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, GermanyGerman Center for Neurodegenerative Diseases (DZNE) Site: Dresden, Dresden, GermanyDepartment of Neurology, University Medicine Greifswald, Greifswald, GermanyGerman Center for Neurodegenerative Diseases (DZNE) Site: Greifswald, Greifswald, GermanySubjective cognitive decline (SCD) is considered an early risk stage for dementia due to Alzheimer's disease (AD) and the development of pathological brain changes, such as the aggregation of amyloid-beta (amyloid-β) plaques. This study evaluates the association between specific features of SCD and cerebral amyloid-β load measured by positron emission tomography (PET) with 18F-florbetaben in 40 cognitively normal older individuals. Global amyloid-β, as well as regional amyloid-β load for the frontal, temporal, parietal, and cingulate cortex, was quantified. Specific features of SCD, such as subjective cognitive complaints and worry, were assessed using the 39-item Everyday Cognition Scales and the 16-item Penn State Worry Questionnaire. Spearman's rank partial correlation analyses, adjusted for age and apolipoprotein E ε4 status, were conducted to test the associations between specific features of SCD and cerebral amyloid-β load. The severity of subjective cognitive complaints in everyday memory and organization was positively correlated with amyloid-β load in the frontal cortex. In addition, the severity of subjective cognitive complaints in everyday planning was positively correlated with amyloid-β load in the parietal cortex. Higher levels of worry were associated with higher amyloid-β load in the frontal cortex. After correction of the PET data for partial volume effects, these associations were reduced to trend level. In conclusion, the severity of subjective cognitive complaints and the level of trait worry were positively associated with cortical amyloid-β burden, particularly in the frontal and parietal cortex. Further studies are required to elucidate the direction of these associations in order to develop strategies to prevent amyloid deposition and cognitive decline.https://www.frontiersin.org/articles/10.3389/fnagi.2021.675583/fullsubjective cognitive declinepreclinical Alzheimer's disease18F-florbetaben PETamyloidbiomarkerscognitively normal
spellingShingle Claudia Schwarz
Claudia Schwarz
Catharina Lange
Gloria S. Benson
Gloria S. Benson
Nora Horn
Nora Horn
Katharina Wurdack
Katharina Wurdack
Mathias Lukas
Mathias Lukas
Ralph Buchert
Ralph Buchert
Miranka Wirth
Agnes Flöel
Agnes Flöel
Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
Frontiers in Aging Neuroscience
subjective cognitive decline
preclinical Alzheimer's disease
18F-florbetaben PET
amyloid
biomarkers
cognitively normal
title Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
title_full Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
title_fullStr Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
title_full_unstemmed Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
title_short Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load
title_sort severity of subjective cognitive complaints and worries in older adults are associated with cerebral amyloid β load
topic subjective cognitive decline
preclinical Alzheimer's disease
18F-florbetaben PET
amyloid
biomarkers
cognitively normal
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.675583/full
work_keys_str_mv AT claudiaschwarz severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT claudiaschwarz severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT catharinalange severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT gloriasbenson severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT gloriasbenson severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT norahorn severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT norahorn severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT katharinawurdack severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT katharinawurdack severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT mathiaslukas severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT mathiaslukas severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT ralphbuchert severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT ralphbuchert severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT mirankawirth severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT agnesfloel severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload
AT agnesfloel severityofsubjectivecognitivecomplaintsandworriesinolderadultsareassociatedwithcerebralamyloidbload